How on-the-wrist sleep apnea detection works
Apple’s new on-wrist sleep apnea detection for the Apple Watch raises questions about how it works, how accurate it can be without continuous blood oxygen monitoring, and why it’s restricted to newer models despite relying heavily on accelerometer data. Commenters debate whether this is genuine hardware and power-budget limitation or artificial product segmentation, especially in light of similar issues around Apple Intelligence and sensor-related patent disputes. The feature is seen as potentially valuable for widening apnea screening once it clears FDA approval, but it also highlights broader frustrations with CPAP gatekeeping, medical regulation, and the reliability of consumer wearables for serious health conditions.
Hardware & Feature Segmentation
- Debate over why sleep apnea detection is limited to Apple Watch Series 9/10 (and not even Ultra 1).
- One side argues it’s largely artificial segmentation, similar to Apple Intelligence being limited to newer iPhones despite cloud processing.
- Others point to plausible technical reasons: newer accelerometers, need for additional sensors (SpO2, possibly temperature), higher compute, and battery constraints.
- Some accept Apple’s pattern of withholding technically-possible features if they degrade user experience (speed, battery).
Sensors, Patents & FDA Status
- Disagreement over whether apnea detection uses only the accelerometer or also blood oxygen and temperature.
- US models have SpO2 disabled due to a patent dispute; non-US specs still list it, suggesting hardware is present but blocked.
- Speculation that Apple could use optical data “internally” without exposing explicit SpO2 readings.
- Feature is not yet live; commenters say it’s pending FDA clearance.
Accuracy & Role of Watch-Based Detection
- Dedicated PAT-based devices and full sleep studies use multiple channels (SpO2, ECG, airflow, belts, video) and even then can be ambiguous.
- Many view watch detection as a screening tool akin to AFib alerts, not a definitive diagnosis.
- Concerns that intermittent SpO2 sampling on watches may miss short desaturations, though long-term nightly data could still be useful.
Oxygen Monitoring & Battery Life
- Some wish for continuous nocturnal SpO2, but others cite battery and regulatory limits.
- Apple aggressively duty-cycles sensors to hit ~18‑hour life; critics argue Apple over-prioritizes screen/CPU over multi-day health tracking.
- Users share charging strategies (during shower, coffee, commute) and note better life on Ultra models.
CPAP Access, Regulation & Market Structure
- Strong frustration with gatekeeping: prescriptions, insurance delays, repeated studies, and cost.
- Some advocate OTC, mass-market CPAPs with user-adjustable pressure, arguing risks of self-titration are lower than untreated apnea.
- Others stress the need for regulation and physician oversight, citing complexity of correct use and examples like Philips’ foam recall and CPAP-related deaths.
- Side discussion on at-home tests, online vendors, and using hidden “service menus” to tweak settings.
Alternative Remedies & Fringe Ideas
- Mouth taping and a 19th‑century “shut your mouth” book spark heavy skepticism; critics emphasize lack of modern evidence and safety concerns.
- Another commenter’s claim that briefly increasing head blood pressure can “100% fix” apnea and myopia is widely challenged as implausible.
- Cheap off-brand watches with SpO2 are warned against due to reports of obviously fake readings.